Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

GBOOY vs. SOFI: Which Stock Is the Better Value Option?
GBOOY vs. SOFI: Which Stock Is the Better Value Option?

Investors interested in Financial - Miscellaneous Services stocks are likely familiar with Grupo Financiero Banorte SAB de CV (GBOOY) and SoFi Technologies, Inc. (SOFI). But which of these two

Energy ETFs in Spotlight With Gasoline Price Predicted to Drop in 2026: https://staticx-tuner.zacks.com/images/articles/main/01/22440.jpg
Energy ETFs in Spotlight With Gasoline Price Predicted to Drop in 2026

Per a recent projection by the U.S. Energy Information Administration (“EIA”), U.S. gasoline prices will decline 6% in 2026. While lower prices at the pump come as a much-needed breather for U.S

Enbridge Shares Rally Toward 52-Week High: Buy the Strength or Wait?
Enbridge Shares Rally Toward 52-Week High: Buy the Strength or Wait?

Enbridge Inc. ENB shares are quickly climbing toward its 52-week high of $50.54, closing at $47.13 on Jan. 20. Notably, the stock has also outperformed its industry peers, including Kinder Morgan

D.R. Horton Stock Tests Support Following Earnings Report: https://www.marketbeat.com/logos/articles/med_20260120122100_dr.png
D.R. Horton Stock Tests Support Following Earnings Report

Shares of homebuilder D.R. Horton Inc. (NYSE: DHI) are down about 1% in mid-day trading after the company reported its earnings for the first quarter of its 2026 fiscal year. This came despite

Zacks Initiates Coverage of MSGM With Outperform Recommendation
Zacks Initiates Coverage of MSGM With Outperform Recommendation

Zacks Investment Research has recently initiated coverage of Motorsport Games Inc. MSGM with an “Outperform” recommendation, reflecting our view that the company has entered a structurally improved

Travelers Q4 Earnings Beat on Strong Net Investment Income
Travelers Q4 Earnings Beat on Strong Net Investment Income

The Travelers Companies, Inc. TRV reported fourth-quarter 2025 core income of $11.13 per share, which beat the Zacks Consensus Estimate by 32% and improved 22% year over year. The improvement was

DELL's Strong Partner Network Drives Up ISG Growth: What's Ahead?
DELL's Strong Partner Network Drives Up ISG Growth: What's Ahead?

Dell Technologies DELL is benefiting significantly from its robust partner network, which has been a key driver of growth in its Infrastructure Solutions Group (ISG). In the third quarter of fiscal

MRVL vs. LITE: Which AI Connectivity Stock is a Safer Bet?
MRVL vs. LITE: Which AI Connectivity Stock is a Safer Bet?

Marvell Technology MRVL and Lumentum Holdings LITE are two prominent players in the AI connectivity space, offering semiconductor solutions that are crucial for networking in data centers and high

Netflix Earnings: Good or Bad?
Netflix Earnings: Good or Bad?

The 2025 Q4 earnings season is now in full swing, with a wide variety of companies reporting results in each of the coming weeks. It looks to be another period of positivity, underpinned by a large

Serve Enters Healthcare With Diligent Robotics Acquisition
Serve Enters Healthcare With Diligent Robotics Acquisition

Serve Robotics Inc. SERV has expanded its footprint into the healthcare sector with the announced acquisition of Diligent Robotics, a leading provider of AI-powered robot assistants for hospitals

Can Realty Income's Broad Reach Shield It and Drive Superior Returns?
Can Realty Income's Broad Reach Shield It and Drive Superior Returns?

Realty Income’s O ability to pay monthly dividends for 667 straight months is closely tied to how its portfolio is structured. The REIT owns more than 15,500 properties leased to more than 1,600

Pre-Markets in the Green After Trump's Comments at Davos
Pre-Markets in the Green After Trump's Comments at Davos

President Trump has arrived in Davos, Switzerland this morning, and presently at the podium for the annual World Economic Forum. This is, quite succinctly, the main even of this year’s forum — with

SMCI vs. META: Which AI Infrastructure Stock Has an Edge Now?
SMCI vs. META: Which AI Infrastructure Stock Has an Edge Now?

Super Micro Computer SMCI and Meta Platforms META are two prominent AI enablers, playing slightly different roles in the AI infrastructure supply chain. While SMCI positions itself as the supplier

GM vs. RACE: Which Auto-Manufacturer Stock Is the Better Buy Now?: https://staticx-tuner.zacks.com/images/articles/main/57/141355.webp
GM vs. RACE: Which Auto-Manufacturer Stock Is the Better Buy Now?

General Motors Company GM and Ferrari N.V. RACE are popular names in the automobile industry. While General Motors, along with its strategic partners, produces, sells and services passenger cars

PRGS Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Up
PRGS Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Up

Progress Software PRGS reported fourth-quarter fiscal 2025 non-GAAP earnings of $1.23 per share, which beat the Zacks Consensus Estimate by 20.59% and increased 14.9% year over year.  Non-GAAP

Prologis Q4 FFO Meets Estimates, Rental Revenues Rise Y/Y
Prologis Q4 FFO Meets Estimates, Rental Revenues Rise Y/Y

Prologis, Inc. PLD reported fourth-quarter 2025 core funds from operations (FFO) per share of $1.44, meeting the Zacks Consensus Estimate. This compares unfavorably with the year-ago quarter’s

NVTS vs. ADI: Which Semiconductor Stock Should You Buy Right Now?
NVTS vs. ADI: Which Semiconductor Stock Should You Buy Right Now?

Navitas Semiconductor NVTS and Analog Devices ADI are two key players operating in the semiconductor industry. They benefit from the growing demand for data centers, artificial intelligence (AI)

CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February
CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February

Capricor Therapeutics CAPR recently provided a regulatory update on its Biologics License Application (BLA) for Deramiocel, following recent interactions with the FDA. After reviewing topline data

ImmunityBio Stock Soars on FDA Talks for Anktiva sBLA Resubmission
ImmunityBio Stock Soars on FDA Talks for Anktiva sBLA Resubmission

Shares of ImmunityBio IBRX surged 17.4% after it announced a recent face-to-face meeting with senior FDA officials to align on the regulatory path forward for Anktiva in an additional indication

Notes on President Trump's Davos Speech: https://staticx-tuner.zacks.com/images/articles/main/84/143058.webp
Notes on President Trump's Davos Speech

Wednesday, January 21st, 2026President Trump has arrived in Davos, Switzerland this morning, and presently at the podium for the annual World Economic Forum. This is, quite succinctly, the main even

Riot Platforms: A $311M AMD Deal Changes the HPC Game: https://www.marketbeat.com/logos/articles/med_20260120120454_riot-platforms-a-311m-amd-deal-changes-the-hpc-gam.png
Riot Platforms: A $311M AMD Deal Changes the HPC Game

In mid-January, the financial markets witnessed a notable anomaly. While Bitcoin's ($BTC) price faced significant downward pressure, dropping toward $91,000 due to rising geopolitical tensions

Can Vertiv's International Expansion Drive More Upside in the Stock?
Can Vertiv's International Expansion Drive More Upside in the Stock?

Vertiv VRT is benefiting from strong international demand for data center infrastructure, driven by the global acceleration of digital transformation and AI adoption. The company reported a robust

Can B&G Foods' Margin Improvement Hold Amid Soft Demand?
Can B&G Foods' Margin Improvement Hold Amid Soft Demand?

B&G Foods, Inc.’s BGS third-quarter fiscal 2025 results reflect a difficult operating backdrop. Net sales declined 4.7% year over year to $439.3 million, while base business net sales, excluding

FDA Grants Breakthrough Therapy Tag to LLY's Ovarian Cancer Candidate
FDA Grants Breakthrough Therapy Tag to LLY's Ovarian Cancer Candidate

Eli Lilly and Company LLY announced that the FDA has granted a Breakthrough Therapy designation to its novel folate receptor alpha (FRα) antibody-drug conjugate (ADC), sofetabart mipitecan

SIFCO Plunges 14.3% in the Past Three Months: How to Play the Stock?
SIFCO Plunges 14.3% in the Past Three Months: How to Play the Stock?

SIFCO Industries, Inc.'s SIF investors have been experiencing some short-term losses from the stock of late. Shares of the Cleveland, OH-based manufacturer of forgings, sub-assemblies and machined